Global Infection and Infection POCT Testing Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infection and Infection POCT Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Equipment
1.2.3 Test Kit
1.2.4 Other
1.3 Market by Application
1.3.1 Global Infection and Infection POCT Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infection and Infection POCT Testing Market Perspective (2021–2032)
2.2 Global Infection and Infection POCT Testing Growth Trends by Region
2.2.1 Global Infection and Infection POCT Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Infection and Infection POCT Testing Historic Market Size by Region (2021–2026)
2.2.3 Infection and Infection POCT Testing Forecasted Market Size by Region (2027–2032)
2.3 Infection and Infection POCT Testing Market Dynamics
2.3.1 Infection and Infection POCT Testing Industry Trends
2.3.2 Infection and Infection POCT Testing Market Drivers
2.3.3 Infection and Infection POCT Testing Market Challenges
2.3.4 Infection and Infection POCT Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infection and Infection POCT Testing Players by Revenue
3.1.1 Global Top Infection and Infection POCT Testing Players by Revenue (2021–2026)
3.1.2 Global Infection and Infection POCT Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Infection and Infection POCT Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Infection and Infection POCT Testing Revenue
3.4 Global Infection and Infection POCT Testing Market Concentration Ratio
3.4.1 Global Infection and Infection POCT Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infection and Infection POCT Testing Revenue in 2025
3.5 Global Key Players of Infection and Infection POCT Testing Head Offices and Areas Served
3.6 Global Key Players of Infection and Infection POCT Testing, Products and Applications
3.7 Global Key Players of Infection and Infection POCT Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Infection and Infection POCT Testing Breakdown Data by Type
4.1 Global Infection and Infection POCT Testing Historic Market Size by Type (2021–2026)
4.2 Global Infection and Infection POCT Testing Forecasted Market Size by Type (2027–2032)
5 Infection and Infection POCT Testing Breakdown Data by Application
5.1 Global Infection and Infection POCT Testing Historic Market Size by Application (2021–2026)
5.2 Global Infection and Infection POCT Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Infection and Infection POCT Testing Market Size (2021–2032)
6.2 North America Infection and Infection POCT Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Infection and Infection POCT Testing Market Size by Country (2021–2026)
6.4 North America Infection and Infection POCT Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infection and Infection POCT Testing Market Size (2021–2032)
7.2 Europe Infection and Infection POCT Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Infection and Infection POCT Testing Market Size by Country (2021–2026)
7.4 Europe Infection and Infection POCT Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Infection and Infection POCT Testing Market Size (2021–2032)
8.2 Asia-Pacific Infection and Infection POCT Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Infection and Infection POCT Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Infection and Infection POCT Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Infection and Infection POCT Testing Market Size (2021–2032)
9.2 Latin America Infection and Infection POCT Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Infection and Infection POCT Testing Market Size by Country (2021–2026)
9.4 Latin America Infection and Infection POCT Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infection and Infection POCT Testing Market Size (2021–2032)
10.2 Middle East & Africa Infection and Infection POCT Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Infection and Infection POCT Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Infection and Infection POCT Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SERION Immunologics
11.1.1 SERION Immunologics Company Details
11.1.2 SERION Immunologics Business Overview
11.1.3 SERION Immunologics Infection and Infection POCT Testing Introduction
11.1.4 SERION Immunologics Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.1.5 SERION Immunologics Recent Development
11.2 SD BIOSENSOR
11.2.1 SD BIOSENSOR Company Details
11.2.2 SD BIOSENSOR Business Overview
11.2.3 SD BIOSENSOR Infection and Infection POCT Testing Introduction
11.2.4 SD BIOSENSOR Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.2.5 SD BIOSENSOR Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Infection and Infection POCT Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Infection and Infection POCT Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Infection and Infection POCT Testing Introduction
11.5.4 Abbott Laboratories Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Details
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Infection and Infection POCT Testing Introduction
11.6.4 Roche Diagnostics Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.6.5 Roche Diagnostics Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Infection and Infection POCT Testing Introduction
11.7.4 BioMerieux Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.7.5 BioMerieux Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Infection and Infection POCT Testing Introduction
11.8.4 PerkinElmer Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.8.5 PerkinElmer Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Infection and Infection POCT Testing Introduction
11.9.4 Enzo Life Sciences Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.9.5 Enzo Life Sciences Recent Development
11.10 Abcam
11.10.1 Abcam Company Details
11.10.2 Abcam Business Overview
11.10.3 Abcam Infection and Infection POCT Testing Introduction
11.10.4 Abcam Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.10.5 Abcam Recent Development
11.11 DRG International
11.11.1 DRG International Company Details
11.11.2 DRG International Business Overview
11.11.3 DRG International Infection and Infection POCT Testing Introduction
11.11.4 DRG International Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.11.5 DRG International Recent Development
11.12 Creative Diagnostics
11.12.1 Creative Diagnostics Company Details
11.12.2 Creative Diagnostics Business Overview
11.12.3 Creative Diagnostics Infection and Infection POCT Testing Introduction
11.12.4 Creative Diagnostics Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.12.5 Creative Diagnostics Recent Development
11.13 Beyotime
11.13.1 Beyotime Company Details
11.13.2 Beyotime Business Overview
11.13.3 Beyotime Infection and Infection POCT Testing Introduction
11.13.4 Beyotime Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.13.5 Beyotime Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Infection and Infection POCT Testing Introduction
11.14.4 GenScript Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.14.5 GenScript Recent Development
11.15 Kehua Biotech
11.15.1 Kehua Biotech Company Details
11.15.2 Kehua Biotech Business Overview
11.15.3 Kehua Biotech Infection and Infection POCT Testing Introduction
11.15.4 Kehua Biotech Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.15.5 Kehua Biotech Recent Development
11.16 Mindray Medical
11.16.1 Mindray Medical Company Details
11.16.2 Mindray Medical Business Overview
11.16.3 Mindray Medical Infection and Infection POCT Testing Introduction
11.16.4 Mindray Medical Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.16.5 Mindray Medical Recent Development
11.17 Antu Biotech
11.17.1 Antu Biotech Company Details
11.17.2 Antu Biotech Business Overview
11.17.3 Antu Biotech Infection and Infection POCT Testing Introduction
11.17.4 Antu Biotech Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.17.5 Antu Biotech Recent Development
11.18 BD
11.18.1 BD Company Details
11.18.2 BD Business Overview
11.18.3 BD Infection and Infection POCT Testing Introduction
11.18.4 BD Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.18.5 BD Recent Development
11.19 Siemens
11.19.1 Siemens Company Details
11.19.2 Siemens Business Overview
11.19.3 Siemens Infection and Infection POCT Testing Introduction
11.19.4 Siemens Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.19.5 Siemens Recent Development
11.20 Qiagen
11.20.1 Qiagen Company Details
11.20.2 Qiagen Business Overview
11.20.3 Qiagen Infection and Infection POCT Testing Introduction
11.20.4 Qiagen Revenue in Infection and Infection POCT Testing Business (2021–2026)
11.20.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Infection and Infection POCT Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Equipment
Table 3. Key Players of Test Kit
Table 4. Key Players of Other
Table 5. Global Infection and Infection POCT Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Infection and Infection POCT Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Infection and Infection POCT Testing Market Size by Region (US$ Million), 2021–2026
Table 8. Global Infection and Infection POCT Testing Market Share by Region (2021–2026)
Table 9. Global Infection and Infection POCT Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Infection and Infection POCT Testing Market Share by Region (2027–2032)
Table 11. Infection and Infection POCT Testing Market Trends
Table 12. Infection and Infection POCT Testing Market Drivers
Table 13. Infection and Infection POCT Testing Market Challenges
Table 14. Infection and Infection POCT Testing Market Restraints
Table 15. Global Infection and Infection POCT Testing Revenue by Players (US$ Million), 2021–2026
Table 16. Global Infection and Infection POCT Testing Market Share by Players (2021–2026)
Table 17. Global Top Infection and Infection POCT Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infection and Infection POCT Testing Revenue, 2025
Table 18. Ranking of Global Top Infection and Infection POCT Testing Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Infection and Infection POCT Testing Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Infection and Infection POCT Testing, Headquarters and Area Served
Table 21. Global Key Players of Infection and Infection POCT Testing, Products and Applications
Table 22. Global Key Players of Infection and Infection POCT Testing, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Infection and Infection POCT Testing Market Size by Type (US$ Million), 2021–2026
Table 25. Global Infection and Infection POCT Testing Revenue Market Share by Type (2021–2026)
Table 26. Global Infection and Infection POCT Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Infection and Infection POCT Testing Revenue Market Share by Type (2027–2032)
Table 28. Global Infection and Infection POCT Testing Market Size by Application (US$ Million), 2021–2026
Table 29. Global Infection and Infection POCT Testing Revenue Market Share by Application (2021–2026)
Table 30. Global Infection and Infection POCT Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Infection and Infection POCT Testing Revenue Market Share by Application (2027–2032)
Table 32. North America Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Infection and Infection POCT Testing Market Size by Country (US$ Million), 2021–2026
Table 34. North America Infection and Infection POCT Testing Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Infection and Infection POCT Testing Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Infection and Infection POCT Testing Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Infection and Infection POCT Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Infection and Infection POCT Testing Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Infection and Infection POCT Testing Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Infection and Infection POCT Testing Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Infection and Infection POCT Testing Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Infection and Infection POCT Testing Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Infection and Infection POCT Testing Market Size by Country (US$ Million), 2027–2032
Table 47. SERION Immunologics Company Details
Table 48. SERION Immunologics Business Overview
Table 49. SERION Immunologics Infection and Infection POCT Testing Product
Table 50. SERION Immunologics Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 51. SERION Immunologics Recent Development
Table 52. SD BIOSENSOR Company Details
Table 53. SD BIOSENSOR Business Overview
Table 54. SD BIOSENSOR Infection and Infection POCT Testing Product
Table 55. SD BIOSENSOR Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 56. SD BIOSENSOR Recent Development
Table 57. Bio-Rad Laboratories Company Details
Table 58. Bio-Rad Laboratories Business Overview
Table 59. Bio-Rad Laboratories Infection and Infection POCT Testing Product
Table 60. Bio-Rad Laboratories Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 61. Bio-Rad Laboratories Recent Development
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Infection and Infection POCT Testing Product
Table 65. Thermo Fisher Scientific Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Infection and Infection POCT Testing Product
Table 70. Abbott Laboratories Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 71. Abbott Laboratories Recent Development
Table 72. Roche Diagnostics Company Details
Table 73. Roche Diagnostics Business Overview
Table 74. Roche Diagnostics Infection and Infection POCT Testing Product
Table 75. Roche Diagnostics Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 76. Roche Diagnostics Recent Development
Table 77. BioMerieux Company Details
Table 78. BioMerieux Business Overview
Table 79. BioMerieux Infection and Infection POCT Testing Product
Table 80. BioMerieux Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 81. BioMerieux Recent Development
Table 82. PerkinElmer Company Details
Table 83. PerkinElmer Business Overview
Table 84. PerkinElmer Infection and Infection POCT Testing Product
Table 85. PerkinElmer Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 86. PerkinElmer Recent Development
Table 87. Enzo Life Sciences Company Details
Table 88. Enzo Life Sciences Business Overview
Table 89. Enzo Life Sciences Infection and Infection POCT Testing Product
Table 90. Enzo Life Sciences Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 91. Enzo Life Sciences Recent Development
Table 92. Abcam Company Details
Table 93. Abcam Business Overview
Table 94. Abcam Infection and Infection POCT Testing Product
Table 95. Abcam Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 96. Abcam Recent Development
Table 97. DRG International Company Details
Table 98. DRG International Business Overview
Table 99. DRG International Infection and Infection POCT Testing Product
Table 100. DRG International Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 101. DRG International Recent Development
Table 102. Creative Diagnostics Company Details
Table 103. Creative Diagnostics Business Overview
Table 104. Creative Diagnostics Infection and Infection POCT Testing Product
Table 105. Creative Diagnostics Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 106. Creative Diagnostics Recent Development
Table 107. Beyotime Company Details
Table 108. Beyotime Business Overview
Table 109. Beyotime Infection and Infection POCT Testing Product
Table 110. Beyotime Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 111. Beyotime Recent Development
Table 112. GenScript Company Details
Table 113. GenScript Business Overview
Table 114. GenScript Infection and Infection POCT Testing Product
Table 115. GenScript Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 116. GenScript Recent Development
Table 117. Kehua Biotech Company Details
Table 118. Kehua Biotech Business Overview
Table 119. Kehua Biotech Infection and Infection POCT Testing Product
Table 120. Kehua Biotech Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 121. Kehua Biotech Recent Development
Table 122. Mindray Medical Company Details
Table 123. Mindray Medical Business Overview
Table 124. Mindray Medical Infection and Infection POCT Testing Product
Table 125. Mindray Medical Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 126. Mindray Medical Recent Development
Table 127. Antu Biotech Company Details
Table 128. Antu Biotech Business Overview
Table 129. Antu Biotech Infection and Infection POCT Testing Product
Table 130. Antu Biotech Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 131. Antu Biotech Recent Development
Table 132. BD Company Details
Table 133. BD Business Overview
Table 134. BD Infection and Infection POCT Testing Product
Table 135. BD Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 136. BD Recent Development
Table 137. Siemens Company Details
Table 138. Siemens Business Overview
Table 139. Siemens Infection and Infection POCT Testing Product
Table 140. Siemens Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 141. Siemens Recent Development
Table 142. Qiagen Company Details
Table 143. Qiagen Business Overview
Table 144. Qiagen Infection and Infection POCT Testing Product
Table 145. Qiagen Revenue in Infection and Infection POCT Testing Business (US$ Million), 2021–2026
Table 146. Qiagen Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report


List of Figures
Figure 1. Infection and Infection POCT Testing Picture
Figure 2. Global Infection and Infection POCT Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Infection and Infection POCT Testing Market Share by Type: 2025 vs 2032
Figure 4. Equipment Features
Figure 5. Test Kit Features
Figure 6. Other Features
Figure 7. Global Infection and Infection POCT Testing Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Infection and Infection POCT Testing Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Infection and Infection POCT Testing Report Years Considered
Figure 13. Global Infection and Infection POCT Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Infection and Infection POCT Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Infection and Infection POCT Testing Market Share by Region: 2025 vs 2032
Figure 16. Global Infection and Infection POCT Testing Market Share by Players in 2025
Figure 17. Global Infection and Infection POCT Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Infection and Infection POCT Testing Revenue in 2025
Figure 19. North America Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Infection and Infection POCT Testing Market Share by Country (2021–2032)
Figure 21. United States Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Infection and Infection POCT Testing Market Share by Country (2021–2032)
Figure 25. Germany Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Infection and Infection POCT Testing Market Share by Region (2021–2032)
Figure 33. China Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Infection and Infection POCT Testing Market Share by Country (2021–2032)
Figure 41. Mexico Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Infection and Infection POCT Testing Market Share by Country (2021–2032)
Figure 45. Israel Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Infection and Infection POCT Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. SERION Immunologics Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 49. SD BIOSENSOR Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 52. Abbott Laboratories Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 53. Roche Diagnostics Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 54. BioMerieux Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 55. PerkinElmer Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 56. Enzo Life Sciences Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 57. Abcam Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 58. DRG International Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 59. Creative Diagnostics Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 60. Beyotime Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 61. GenScript Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 62. Kehua Biotech Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 63. Mindray Medical Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 64. Antu Biotech Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 65. BD Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 66. Siemens Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 67. Qiagen Revenue Growth Rate in Infection and Infection POCT Testing Business (2021–2026)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit